Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A phase I study of vinorelbine, cyclophosphamide and Rapamycin for recurrent malignancies in children
Protocol ID
ACCT007 (Rap-CV)
Disease (Sub Disease)
Malignancies
Diagnosis Stage
Relapsed/refractory
Location
NSW, VIC, WA, SA, NZ
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Trial Status
Open
Sites
The Children's Hospital at Westmead
Monash Children's Hospital
Perth Children's Hospital
Royal Children's Hospital
Women's & Children's Hospital
Christchurch Hospital
Starship Hospital
Study Type
Treatment
Phase
Phase 1
Age Eligibility
up to 21 Years
ANZCTR
ACTRN12613000423718
Back to Registry
Study Title A phase I study of vinorelbine cyclophosphamide and Rapamycin for recurrent malignancies in children
Protocol ID ACCT007 (Rap-CV)
Disease (Sub Disease) Malignancies
Diagnosis Stage Relapsed/refractory
Location NSW / VIC / WA / SA / NZ
Sponsor Australian and New Zealand Children's Haematology Oncology Group
Links http://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12613000423718
Trial Status Open
Trial Open Date 09/08/2019
Sites The Children's Hospital at Westmead / Monash Children's Hospital / Perth Children's Hospital / Royal Children's Hospital / Women's & Children's Hospital / Christchurch Hospital / Starship Hospital/
Study Type Treatment
Phase Phase 1
Age Eligibility up to 21 Years
ANZCTR ACTRN12613000423718